{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:28:47Z","timestamp":1771057727610,"version":"3.50.1"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Approximately 50% of cases of recurrent pregnancy loss (RPL) remain unexplained, and there is a lack of consensus concerning the effective treatments for idiopathic RPL. We used network meta-analyses to evaluate the efficacy of several prophylactic therapeutic interventions used in women with idiopathic RPL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>We conducted a systematic literature search using several databases from their inceptions to 20 July 2023. References from key articles were also manually searched. Randomized controlled trials assessing the efficacy and safety of any prophylactic intervention that were conducted in adult women with RPL were included. Studies with known causes of RPL were excluded. Two reviewers independently extracted data and assessed the risk of bias. Primary outcomes were live births and miscarriage rates. Secondary outcomes included serious adverse\/adverse events and trial discontinuation. The network meta-analyses used a Bayesian hierarchical model with direct and indirect comparisons. Rank probabilities (assessed by surface under the cumulative ranking curve [SUCRA]) and certainty of evidence (assessed by Grading Recommendations Assessment, Development, and Evaluation [GRADE]) were also assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty-eight studies (6,379 participants) were evaluated. No statistically significant differences in live birth rates among the interventions were found. The three best-ranked interventions for this outcome were prednisone plus progesterone plus aspirin (83%), leukocyte immune therapy (74%), and prednisolone (65%). Women who were treated with progesterone plus human chorionic gonadotrophin (instead of a placebo) presented an increase in miscarriage odds (odds ratio [OR] 3.83, 95% credible intervals [CrIs] 1.04\u201314.38). The three best-ranked interventions for miscarriage rate were prednisone plus progesterone plus aspirin (SUCRA\u202f=\u202f81%), hydroxychloroquine (SUCRA\u202f=\u202f79%), and intralipid (SUCRA\u202f=\u202f65%). Overall, under placebo, 59% (95% confidence interval [CI] 51\u201367; I<jats:sup>2<\/jats:sup>\u202f=\u202f92%) of participants underwent successful live births, and 35% (95% CI 30\u201342, I<jats:sup>2<\/jats:sup>\u202f=\u202f86%) underwent miscarriages. We found no evidence of statistically significant differences between interventions (the top three interventions were low-molecular-weight heparin, granulocyte colony-stimulating factor, and leukocyte immune therapy) in those who discontinued trial participation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results suggest that none of the analyzed interventions led to improvements in the live birth rate or a reduction in the miscarriage rate in women with idiopathic RPL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/prospero<\/jats:uri>, identifier CRD42023455668.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1569819","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:11:03Z","timestamp":1747195863000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of therapeutic interventions for idiopathic recurrent pregnancy loss: a systematic review and network meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Jorge","family":"Lima","sequence":"first","affiliation":[]},{"given":"Jo\u00e3o","family":"Guerreiro","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"\u00c2ngelo-Dias","sequence":"additional","affiliation":[]},{"given":"Sofia Silv\u00e9rio","family":"Serra","sequence":"additional","affiliation":[]},{"given":"Teresa","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Nat\u00e1lia","family":"Marto","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Feldman","family":"de Pinho","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Rodrigo","family":"Ruano","sequence":"additional","affiliation":[]},{"given":"Gon\u00e7alo Silva","family":"Duarte","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"ref1","first-page":"hoad002","article-title":"ESHRE guideline: recurrent pregnancy loss: an update in 2022","volume-title":"Hum Reprod Open","author":"Bender Atik","year":"2023"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/AOG.0000000000005498","article-title":"Evaluation of recurrent pregnancy loss","volume":"143","author":"de Assis","year":"2024","journal-title":"Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/inf.1979.11.issue-2.12","article-title":"The prevalence of toxoplasma antibodies among 11, 736 pregnant women in Norway","volume":"11","author":"Stray-Pedersen","year":"1979","journal-title":"Scand J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1447-0756.2012.01973.x","article-title":"Frequency of recurrent spontaneous abortion and its influence on further marital relationship and illness: the Okazaki cohort study in Japan","volume":"39","author":"Sugiura-Ogasawara","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0015-0282(16)58382-4","article-title":"Frequency of factors associated with habitual abortion in 197 couples","volume":"66","author":"Stephenson","year":"1996","journal-title":"Fertil Steril"},{"key":"ref6","first-page":"76","article-title":"Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev","volume":"2","author":"Ford","year":"2009","journal-title":"Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1741-7015-11-154","article-title":"New insights into mechanisms behind miscarriage","volume":"11","author":"Larsen","year":"2013","journal-title":"BMC Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-4471-1658-5_2","article-title":"The epidemiology of repeated abortion","volume-title":"Early pregnancy loss","author":"Alberman","year":"1988"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.fertnstert.2019.11.025","article-title":"Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"113","year":"2020","journal-title":"Fertil Steril"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jgyn.2014.09.010","article-title":"Definition of pregnancy losses: standardization of terminology from the French National College of obstetricians and gynecologists (CNGOF)","volume":"43","author":"Delabaere","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1111\/1471-0528.17515","article-title":"Recurrent miscarriage green-top guideline no. 17","volume":"130","author":"Regan","year":"2023","journal-title":"BJOG"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1056\/NEJMcp1005330","article-title":"Clinical practice. Recurrent miscarriage","volume":"363","author":"Branch","year":"2010","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/0974-1208.142475","article-title":"Evidence-based management of recurrent miscarriages","volume":"7","author":"Jeve","year":"2014","journal-title":"J Hum Reprod Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10815-017-1108-y","article-title":"Genetic and epigenetic variations associated with idiopathic recurrent pregnancy loss","volume":"35","author":"Arias-Sosa","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm12124074","article-title":"Recurrent pregnancy loss etiology, risk factors, diagnosis, and management. Fresh look into a full box","volume":"12","author":"Turesheva","year":"2023","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/s0015-0282(16)58382-4","article-title":"Frequency of factors associated with habitual abortion in 197 couples","volume":"66","author":"Daya","year":"1996","journal-title":"Fertil Steril"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/humrep\/dev014","article-title":"Depression and emotional stress is highly prevalent among women with recurrent pregnancy loss","volume":"30","author":"Kolte","year":"2015","journal-title":"Hum Reprod"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/aogs.13352","article-title":"Treatment efficacy for idiopathic recurrent pregnancy loss - a systematic review and meta-analyses","volume":"97","author":"Rasmark Roepke","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1093\/humrep\/del150","article-title":"Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage","volume":"21","author":"Jauniaux","year":"2006","journal-title":"Hum Reprod"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000365973","article-title":"Recurrent spontaneous miscarriage is still a challenging diagnostic and therapeutic quagmire","volume":"24","author":"Diejomaoh","year":"2015","journal-title":"Med Princ Pract"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1600-0897.2012.01121.x","article-title":"Multiple pregnancy failures: an immunological paradigm","volume":"67","author":"Matthiesen","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"ref24","author":"Lima","year":"2023"},{"key":"ref25","year":"1995"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Mak"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3758\/s13423-016-1015-8","article-title":"A simple introduction to Markov chain Monte-Carlo sampling","volume":"25","author":"van Ravenzwaaij","year":"2018","journal-title":"Psychon Bull Rev"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jclinepi.2018.11.025","article-title":"GRADE approach to rate the certainty from a network meta-analysis: addressing incoherence","volume":"108","author":"Brignardello-Petersen","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/aogs.13420","article-title":"Acetylsalicylic acid does not prevent first-trimester unexplained recurrent pregnancy loss: a randomized controlled trial","volume":"97","author":"Blomqvist","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.intimp.2016.09.018","article-title":"Clinical observation of lymphocyte active immunotherapy in 380 patients with unexplained recurrent spontaneous abortion","volume":"40","author":"Chen","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/1471-0528.13192","article-title":"Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial","volume":"122","author":"Christiansen","year":"2014","journal-title":"BJOG"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/oxfordjournals.humrep.a135769","article-title":"Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i. v. Immunoglobulin","volume":"10","author":"Christiansen","year":"1995","journal-title":"Hum Reprod"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/00016349409023451","article-title":"Placebo-controlled trial of active immunization with third party leukocytes in recurrent miscarriage","volume":"73","author":"Christiansen","year":"1994","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1056\/NEJMoa1504927","article-title":"A randomized trial of progesterone in women with recurrent miscarriages","volume":"373","author":"Coomarasamy","year":"2015","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1600-0897.1995.tb00960.x","article-title":"Intravenous immunoglobulin for treatment of recurrent pregnancy loss","volume":"34","author":"Coulam","year":"1995","journal-title":"Am J Reprod Immunol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.fertnstert.2005.12.068","article-title":"A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages","volume":"86","author":"Dolitzky","year":"2006","journal-title":"Fertil Steril"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/humrep\/dey393","article-title":"Recombinant human granulocyte-colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial","volume":"34","author":"Eapen","year":"2019","journal-title":"Hum Reprod"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jsbmb.2005.08.007","article-title":"Dydrogesterone in the reduction of recurrent spontaneous abortion","volume":"97","author":"El-Zibdeh","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1756-0500-7-23","article-title":"Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage","volume":"7","author":"Elmahashi","year":"2014","journal-title":"BMC Res Notes"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00404-007-0527-x","article-title":"Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study","volume":"278","author":"Fawzy","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1600-0897.1993.tb00571.x","article-title":"Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial","volume":"29","author":"Gatenby","year":"1993","journal-title":"Am J Reprod Immunol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1111\/jog.12456","article-title":"Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study","volume":"40","author":"Ghosh","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00404-014-3262-0","article-title":"Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial","volume":"290","author":"Gomaa","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/humrep\/14.3.838","article-title":"Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study","volume":"14","author":"Jablonowska","year":"1999","journal-title":"Hum Reprod"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7196\/SAJOG.2017.v23i1.1112","article-title":"Preventive role of low-molecular-weight heparin in unexplained recurrent pregnancy loss","volume":"23","author":"Khan","year":"2017","journal-title":"S Afr J Obstet Gynaecol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"7878752","DOI":"10.1155\/2021\/7878752","article-title":"Effect of prepregnancy lymphocyte active immunotherapy on unexplained recurrent miscarriage, pregnancy success rate, and maternal-infant outcome","volume":"2021","author":"Li","year":"2021","journal-title":"Biomed Res Int"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00404-015-3922-8","article-title":"Effectiveness and potential mechanisms of intralipid in treating unexplained recurrent spontaneous abortion","volume":"294","author":"Meng","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/jrms.jrms_81_21","article-title":"The effect of low-molecular-weight heparin on live birth rate of patients with unexplained early recurrent pregnancy loss: a two-arm randomized clinical trial","volume":"27","author":"Mohammad-Akbari","year":"2022","journal-title":"J Res Med Sci"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1080\/01443615.2022.2141615","article-title":"The effect of hydroxychloroquine on pregnancy outcomes in patients with unexplained recurrent pregnancy loss: a placebo-controlled study \"pilot study\"","volume":"42","author":"Moini","year":"2022","journal-title":"J Obstet Gynaecol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/0976-9668.166054","article-title":"Comparison of the effect of aspirin and heparin with or without intravenous immunoglobulin in treatment of recurrent abortion with unknown etiology: a clinical study","volume":"6","author":"Nazari","year":"2015","journal-title":"J Nat Sci Biol Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0140-6736(98)12055-X","article-title":"Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial","volume":"354","author":"Ober","year":"1999","journal-title":"Lancet"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1182\/blood-2014-11-610857","article-title":"Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial","volume":"125","author":"Pasquier","year":"2015","journal-title":"Blood"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1093\/humrep\/12.11.2388","article-title":"Short-term therapy for recurrent abortion using intravenous immunoglobulins: results of a double-blind placebo-controlled Italian study","volume":"12","author":"Perino","year":"1997","journal-title":"Hum Reprod"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/s0015-0282(16)56992-1","article-title":"Human chorionic gonadotropin supplementation in recurring pregnancy loss: a controlled trial","volume":"62","author":"Quenby","year":"1994","journal-title":"Fertil Steril"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1093\/humrep\/dep240","article-title":"Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial","volume":"24","author":"Scarpellini","year":"2009","journal-title":"Hum Reprod"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"601","DOI":"10.7326\/M14-2062","article-title":"Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme","volume":"162","author":"Schleussner","year":"2015","journal-title":"Ann Intern Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/1076029616665167","article-title":"Low-molecular-weight heparin for the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: a randomized controlled trial","volume":"23","author":"Shaaban","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1093\/humrep\/deq179","article-title":"Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial","volume":"25","author":"Stephenson","year":"2010","journal-title":"Hum Reprod"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1600-0897.1998.tb00339.x","article-title":"Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial","volume":"39","author":"Stephenson","year":"1998","journal-title":"Am J Reprod Immunol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/humrep\/det117","article-title":"A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant","volume":"28","author":"Tang","year":"2013","journal-title":"Hum Reprod"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1471-0528.1994.tb13584.x","article-title":"Intravenous immunoglobulin in the prevention of recurrent miscarriage. The German RSA\/IVIG group","volume":"101","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.7754\/Clin.Lab.2018.180130","article-title":"Clinical efficacy of low molecular heparin on unexplained recurrent spontaneous abortion","volume":"64","author":"Xu","year":"2018","journal-title":"Clin Lab"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"101527","DOI":"10.1016\/j.eclinm.2022.101527","article-title":"Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: a double-blind, randomised, placebo-controlled trial","volume":"50","author":"Yamada","year":"2022","journal-title":"EClinicalMedicine"},{"key":"ref66","first-page":"379","article-title":"Efficacy of intrauterine injection of granulocyte colony stimulating factor (G-CSF) on treatment of unexplained recurrent miscarriage: a pilot rct study","volume":"18","author":"Zafardoust","year":"2017","journal-title":"J Reprod Infertil"},{"key":"ref67","first-page":"548","article-title":"Evaluation of the efficacy of aspirin and low molecular weight heparin in patients with unexplained recurrent spontaneous abortions","volume":"12","author":"Zolghadri","year":"2010","journal-title":"Iran Red Crescent Med J"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/AOG.0b013e31823c0413","article-title":"Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success?","volume":"119","author":"Lund","year":"2012","journal-title":"Obstet Gynecol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.fertnstert.2020.05.008","article-title":"Parental human leukocyte antigen-C allotypes are predictive of live birth rate and risk of poor placentation in assisted reproductive treatment","volume":"114","author":"Alecsandru","year":"2020","journal-title":"Fertil Steril"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/imr.13087","article-title":"Immunity at maternal-fetal interface: KIR\/HLA (Allo)recognition","volume":"308","author":"Alexandrova","year":"2022","journal-title":"Immunol Rev"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"CD000112","DOI":"10.1002\/14651858.CD000112.pub3","article-title":"Immunotherapy for recurrent miscarriage","volume":"2014","author":"Wong","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/aji.12373","article-title":"Effect of prednisolone administration on patients with unexplained recurrent miscarriage and in routine intracytoplasmic sperm injection: a meta-analysis","volume":"74","author":"Dan","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"e0141588","DOI":"10.1371\/journal.pone.0141588","article-title":"The effects of intravenous immunoglobulins in women with recurrent miscarriages: a systematic review of randomised trials with meta-analyses and trial sequential analyses including individual patient data","volume":"10","author":"Egerup","year":"2015","journal-title":"PLoS One"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/aji.12493","article-title":"Unexplained recurrent miscarriage and recurrent implantation failure: is there a place for immunomodulation?","volume":"76","author":"Mekinian","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.fertnstert.2016.10.031","article-title":"Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials","volume":"107","author":"Saccone","year":"2017","journal-title":"Fertil Steril"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"CD013792","DOI":"10.1002\/14651858.CD013792.pub2","article-title":"Progestogens for preventing miscarriage: a network meta-analysis","volume":"2021","author":"Devall","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"e70037","DOI":"10.1111\/aji.70037","article-title":"Efficacy of corticosteroids in patients with recurrent pregnancy loss: a systematic review and Meta-analysis","volume":"93","author":"D'Ippolito","year":"2025","journal-title":"Am J Reprod Immunol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1569819\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:11:10Z","timestamp":1747195870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1569819\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":77,"alternative-id":["10.3389\/fmed.2025.1569819"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1569819","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"article-number":"1569819"}}